DIRS.INFO The most relevant business & tech news

☆ Here are Tuesday's biggest analyst calls: Nvidia, Tesla, Apple, Live Nation, Boeing, Coinbase, Amazon & more
▼ + stars: | 2024-04-30 | by ( Michael Bloom | ) www.cnbc.com time to read: +5 min

Bank of America reiterates Tesla as buy Bank of America said it's standing by its buy rating on the electric-vehicle maker. "We maintain our Buy rating and raise our PT from $1100 to $1,150." "We are initiating coverage of Live Nation with a Buy rating and $120 price target." "We are initiating coverage on EE with an Overweight rating." "We are initiating coverage of Integral Ad Science with a Buy rating and a $15 price target."

Persons: Tesla, TSLA, Morgan Stanley, Oppenheimer, Raymond James, Mizuho, Airbnb, Coinbase, Needham, Stephens, Jefferies, Ralph Lauren, Chegg Organizations: Argus, Boeing, " Bank of America, Bank of America, UBS, Nvidia, Dyne, JPMorgan, Catalyst Watch, Apple, Mizuho, Citi, BTC, Ethereum, Paramount, CBS, Deutsche Bank, Deutsche, Excelerate Energy, Stephens, Barclays, UMB, Corp, Contineum Locations: Base, Kansas City

One strategist, however is looking keenly at European equities, and notes that "Europe isn't a boring market." "You would hope that will translate through to the stock market in terms of company earnings growth in Europe. "While you might see some kind of short-term downturn, in the longer-term the picture is very positive for the sector," Field added. He sees value in payments, which he described as "one of the most undervalued parts of European financial services." The sector has trailed market performance, with valuations looking "interesting" over the last 12 months, Morningstar noted in its recent report.

Persons: Michael Field, Field, Morningstar Organizations: CNBC Pro, European Central Bank, Consumer, Swatch Group, Financial, Morningstar, ING Bank, Group, Health, Novo Nordisk Locations: U.S, Europe, Netherlands, British, Swiss

☆ Biotech stocks are ready to break out. They just need one more thing
▼ + stars: | 2024-04-10 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +5 min

While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument for stocks in the sector is growing. Last week, Morgan Stanley analysts noted that it is the months leading up to an initial rate cut when biotech stocks outperform. Morgan Stanley also believes the case for biotech stocks is further reinforced by the financing environment and the outlook for mergers and acquisitions as well as upcoming innovation. The case for innovation Morgan Stanley also favors owning biotech stocks that have a strong drug platform even if the key catalyst of clinical trial data and FDA approvals are farther out. Rhythm ranks among the stocks rated overweight that Morgan Stanley favors in this category.

Persons: Morgan Stanley, Needham, Joseph Stringer, dealmaking, Stringer, erosive, it's, Phathom, GERD, LSEG, Merck, — CNBC's Michael Bloom Organizations: Federal Reserve, Nasdaq, Oncology, Immunology, Phathom Pharmaceutical, Pharmaceuticals, Phathom Pharmaceuticals, LSEG, Drug, Bristol Myers Squibb, Pfizer, Intellia Therapeutics, Rocket Pharmaceuticals Locations: New Jersey

☆ Here are Thursday's biggest analyst calls: Nvidia, Meta, Tesla, Apple, CyberArk, Grindr, Estee Lauder & more
▼ + stars: | 2024-03-28 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Thursday's biggest calls on Wall Street: Wells Fargo reiterates Bank of America as overweight Wells Fargo raised its price target on Bank of America to $44 per share from $40. HSBC downgrades Bank of America to hold from buy HSBC downgraded Bank of America mainly on valuation. Benchmark reiterates Nvidia as buy Benchmark said it's standing by its buy rating on Nvidia. Bank of America reiterates Amazon as buy Bank of America said it's bullish on Amazon's investments in AI. "We are initiating coverage on CYBR with a Buy rating and a $317 PT."

Persons: Wells Fargo, Bernstein, it's, Goldman Sachs, Tesla, Goldman, Piper Sandler, Piper, Clark, Kimberly, Claude, Estee Lauder, BTIG, TD Cowen, Cowen, Grindr, William Blair, Bentley, Morgan Stanley, JPMorgan, KeyBanc, Oppenheimer, Monness Crespi Hardt downgrades Palantir, Palantir Organizations: Bank of America, FDIC, Apple, HSBC downgrades Bank of America, HSBC, of America, PNC, Tesla, EV, Kimberly, Nvidia, Amazon, Bentley Systems, Allstate, JPMorgan, Major Pharma, Citi, Boeing, Barclays, Meta, SNAP Locations: mkts, DraftKings

☆ Do you have seasonal allergies? Here’s how to find out and what to do
▼ + stars: | 2024-03-27 | by ( Katia Hetter | ) edition.cnn.com time to read: +8 min

More than 1 in 4 adults and nearly 1 in 5 children have seasonal allergies, according to the US Centers for Disease Control and Prevention. Are there other substances that can cause seasonal allergies? CNN: Are there other substances that can cause seasonal allergies? These are not seasonal allergies, as they aren’t related to environmental exposures and can happen year-round. There are many online resources for reducing allergens in your home that can help to decrease the impact of seasonal allergies.

Persons: CNN —, Leana Wen, It’s, I’ve Organizations: CNN, Northern, US Centers for Disease Control, Nature Communications, George Washington University, CDC

☆ ‘Havana syndrome’: Despite symptoms, NIH research finds no evidence of mysterious ailment in brain scans
▼ + stars: | 2024-03-18 | by ( Katie Bo Lillis | Jen Christensen | ) edition.cnn.com time to read: +9 min

Some current and former CIA officers have raised concerns that a CIA task force in charge of investigating Havana syndrome soft-pedaled its investigation, CNN has previously reported. The control group was small and not perfectly matched to those with Havana syndrome. In the second study, researchers tested hearing, balance, eyesight and neuropsychological state, and they looked at blood biomarkers, in the two groups. Headache was a common concern among the participants with Havana syndrome. The study concluded that whatever caused Havana syndrome seems to create symptoms “without persistent or detectable physiologic changes.

Persons: David Relman, don’t, ” Relman, ’, AHIs, Relman, Trump, ”, Dr, Sanjay Gupta, ” Dr, Leighton Chan Organizations: CNN, National Institutes of Health, Stanford, CIA, AHIs, CNN Health, NIH Locations: Havana, Cuban, Bogota, Colombia, Vienna, Austria

☆ Jefferies likes these dividend-growing stocks for 2024
▼ + stars: | 2024-03-18 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

Investors searching for income could be well-rewarded by turning to dividend-growing stocks, according to Jefferies. "Consensus expects USA dividend growth to accelerate from 3.9% for 2023 to 6.2% for 2024, along with positive revisions," Peramunetilleke wrote in a note Wednesday. JPMorgan Chase , which has a 2.3% 12-month forward dividend yield, is the largest name on the list. AbbVie also made the list with a 12-month forward dividend of 3.5%. McDonald's , which has a 2.4% 12-month forward dividend, also made the cut.

Persons: Peramunetilleke, Jefferies, AbbVie, Robert Michael Organizations: Jefferies, JPMorgan Chase, Therapeutics

☆ FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
▼ + stars: | 2024-03-14 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

The Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that affects millions worldwide. Novo Nordisk and Eli Lilly are testing their respective blockbuster weight loss injections as treatments for the same kind of liver disease, called nonalcoholic steatohepatitis, or NASH. Madrigal's drug, which will be marketed as Rezdiffra, is specifically approved to treat patients with NASH who also have moderate-to-advanced liver scarring. NASH is a serious form of liver disease characterized by excess fat buildup and inflammation in the liver and can lead to liver scarring, also known as fibrosis, along with liver failure and liver cancer. Roughly 6 million to 8 million people in the U.S. have NASH with moderate-to-advanced liver scarring, according to an estimate cited by the FDA.

Persons: Madrigal, Eli Lilly, NASH, Nikolay Nikolov, Rezdiffra Organizations: Madrigal Pharmaceuticals, Drug Administration, Pharmaceuticals, Novo Nordisk, FDA, Immunology Locations: U.S

☆ A man deliberately got 217 Covid shots. Here’s what happened
▼ + stars: | 2024-03-06 | by ( Mira Cheng | ) edition.cnn.com time to read: +7 min

The man, who is not named in the correspondence in compliance with German privacy rules, reported receiving 217 Covid shots between June 2021 and November 2023. Raising suspicionsAccording to his immunization history, the man got his first Covid vaccine in June 2021. The adaptive immune system is the subsection of the immune system that learns to recognize and respond to specific pathogens when you encounter them throughout your life, Miller said. Last week, the CDC updated its guidance to recommend an additional dose of the current Covid vaccine for people 65 and older. Less than a quarter of adults and only 13% of children in the US have gotten the most recently recommended Covid vaccine, according to CDC data.

Persons: hypervaccination ”, ”, Emily Happy Miller, ” Miller, “, Dr, Kilian Schober, Friedrich, hypervaccination, ” Schober, Schober, Miller, Hypervaccination, that’s, Johnson, Sanjay Gupta Organizations: CNN, Albert Einstein College of Medicine, Alexander University Erlangen, Red Cross, RTL, Pfizer, Moderna, Johnson, Sanofi, CNN Health, Centers for Disease Control, CDC Locations: Magdeburg, Nürnberg, Saxony, Dresden, Eilenburg, United States

☆ A 71-year-old explains all the ways she's countering loneliness. They include tacos and a cellphone.
▼ + stars: | 2024-03-05 | by ( Ayelet Sheffey | ) www.businessinsider.com time to read: +5 min

While Skinner said she wasn't in isolation, she was happy — thinking back on it — that her doctor asked that question. AdvertisementSkinner, 71, has adopted "Taco Tuesdays" as one avenue to maintain social connections. When you have better social connections, it just helps your brain stay wired in positive ways." As Skinner works to build connections, she's also doing all she can to make the most out of the time she has each day. Now, her focus is on growing the friendships she's made into deeper relationships, which she said "takes quite a bit of time."

Persons: Susan Skinner, She's, Skinner, Vivek Murthy, it's, crumb, I've, she's, Preeti Malani, who've, Malani, — Organizations: Service, tacos, Facebook, University of Michigan Locations: Nebraska

☆ How some boomers are overcoming loneliness and finding new friendships in retirement: 'It's been a lifesaver'
▼ + stars: | 2024-03-03 | by ( Ayelet Sheffey | ) www.businessinsider.com time to read: +17 min

While loneliness among older adults has been an issue for years, the pandemic exacerbated it across all age groups. Some experts told me that cities could help counter loneliness with policies that bolster senior centers and ensure accessibility to vital resources and that governments should invest more in mitigating loneliness for older adults. That's largely why Lamy felt compelled to organize an easy way for older adults in the community to meet and talk to one another. What we know is that isolation and loneliness among older people tend to lead to pretty serious health complications very quickly. So there is a real reason for us to try to help older people find connection."

Persons: Maria Maki, Maki, Andrea Ellen Reed, Buffalo Community Center Andrea Ellen Reed, I've, Vivek Murthy, Gen Zers, Joe Lamy, Lamy, Jovelle Tamayo, Dianne Stone, winder, he'd, Jan, —, that's, that'll, she'd, There's, they'd, Preeti Malani, who've, Malani, Garey Schmidt, Schmidt, Sedona , Arizona Matt Martian Williams, Matt Martian Williams, Sen, Chris Murphy, Murphy, Rick Grossman, Grossman, Stone, we're, Jeff Keilson, Maura Healey, Keilson, it's, we've, BI Murphy, he's Organizations: Buffalo Community Center, BI, National Council, National Institute of Senior Centers, National, Healthy Aging, University of Michigan, Democratic Locations: Buffalo , Minnesota, Buffalo, Seattle, Las Vegas, New York, Chicago, Sedona , Arizona, Flagstaff, someone's, Sedona, Connecticut, Massachusetts

☆ Drug Drastically Reduces Children’s Reactions to Traces of Food Allergens
▼ + stars: | 2024-02-25 | by ( Roni Caryn Rabin | ) www.nytimes.com time to read: 1 min

A drug that has been used for decades to treat allergic asthma and hives significantly reduced the risk of life-threatening reactions in children with severe food allergies who were exposed to trace amounts of peanuts, cashews, milk and eggs, researchers reported on Sunday. The drug, Xolair, has already been approved by the Food and Drug Administration for adults and children over age 1 with food allergies. It is the first treatment that drastically cuts the risk of serious reactions — like anaphylaxis, a life-threatening allergic reaction that causes the body to go into shock — after accidental exposures to various food allergens. The results of the researchers’ study, presented at the annual conference of the American Academy of Allergy, Asthma and Immunology in Washington, were published in The New England Journal of Medicine.

Organizations: Food and Drug Administration, American Academy of Allergy, Asthma, Immunology, The New England, of Medicine Locations: Washington, The

☆ New data shows asthma medicine may help reduce severe reactions in people with multiple food allergies
▼ + stars: | 2024-02-25 | by ( Amanda Musa | ) edition.cnn.com time to read: +9 min

CNN —A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods. There is no cure for food allergies, and the only other FDA-approved treatment is Palforzia, an oral immunotherapy for peanut allergies in children between 4 and 17 years old. “But the reality is that most of our patients don’t just have peanut allergy,” Wood added. For people who have multiple severe food allergies and even moderate to severe allergic asthma, Casale says, Xolair might be the best treatment option. Xolair does not eliminate food allergies, and unlike with some environmental allergies such as pollen, many people never outgrow them, Casale added.

Persons: ”, Sharon Chinthrajah, “, ” Xolair, Robert Wood, ” Wood, Xolair, Wood, omalizumab, Thomas Casale, Palforzia, Casale, they’ve, ” Lindsey Mathias, Dr, Sanjay Gupta, Chinthrajah, “ We’re Organizations: CNN, New England, of Medicine, US Food and Drug Administration, Stanford University, of Allergy, Immunology, Johns Hopkins Children’s, Genentech, Novartis, FDA, National Institutes of Health, University of South, American Academy of Allergy Asthma, CNN Health, Xolair Locations: anaphylaxis, Eudowood, Johns, University of South Florida Tampa

☆ The woman behind the next big thing in cancer treatment
▼ + stars: | 2024-02-20 | by ( Katie Hunt | ) edition.cnn.com time to read: +12 min

Christine Olsson/AFP/Getty ImagesWu’s research focused on small mutations in cancer tumor cells. However, in many cases, cancer vaccines have failed to live up to their promise — largely because the right target hasn’t been found. “This is a fantastic discovery.”By sequencing DNA from healthy and cancer cells, Wu and her team identified a cancer patient’s unique tumor neoantigens. More work is needed before they are a viable treatment options for many cancer patients. To show that these type of cancer vaccines work, much larger randomized control trials are needed.

Persons: Catherine Wu, Boston’s Dana, “, ”, Wu, Lendahl, Dr Patrick Ott, Sam Ogden, Honjo, James Allison, Tasuku Honjo, James P Allison, Christine Olsson, ” Hans, Gustaf Ljunggren, Matt Stone, “ I’m, ” Wu, ” Lendahl, you’ve, It’s, ” Barbara Brigham, BioNTech, ” CNN’s Brenda Goodman Organizations: CNN, Farber Cancer Institute, Royal Swedish Academy of Sciences, Karolinska, Getty, US Food and Drug Administration, FDA, MediaNews, Boston Herald, Merck, Moderna, ”, Covid Locations: Sweden, BioNTech, Rome

☆ AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
▼ + stars: | 2024-02-20 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. AbbVie on Tuesday said longtime executive Robert Michael will become the company's new CEO, replacing Richard Gonzalez. Michael, who is AbbVie's president and chief operating officer, will become the company's second-ever CEO on July 1. Gonzalez, who has led the company since it spun out from Abbott Laboratories in 2013, will retire and become AbbVie's executive chairman. Now is the opportune time to hand the CEO role over to Rob," Gonzalez said in a release.

Persons: AbbVie, Robert Michael, Richard Gonzalez, Michael, Gonzalez, Rob Organizations: Abbott Laboratories, AbbVie, CNBC PRO Locations: Humira

☆ JPMorgan says buy this immunology stock primed to rally nearly 40%
▼ + stars: | 2024-02-20 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Immunovant could emerge as a key player in the autoimmune space, according to JPMorgan. The bank initiated coverage of the biotech stock at an overweight rating, also setting a price target of $51. That implies that shares of Immunovant could rally more than 37% from their Friday closing price of $37.13. Immunovant stock has slid 9% so far this quarter. IMVT YTD mountain IMVT YTD chart As a key catalyst, the analyst underscored Immunovant's stats as one of the key players using anti-neonatal Fc receptor technology, or anti-FcRn technology, to treat autoimmune diseases.

Persons: Brian Cheng, Graves, Cheng, — CNBC's Michael Bloom Organizations: JPMorgan, IMVT, Telavant, Merck, Prometheus Locations: Immunovant, IMVT, Roche

☆ Smoking’s effects on the immune system can last years, study finds
▼ + stars: | 2024-02-14 | by ( Jen Christensen | ) edition.cnn.com time to read: +5 min

They exposed the blood samples to common germs like E. coli bacteria and the flu virus and measured the immune response. It had nearly the same impact on immune response as important factors such as age or sex. The innate immune response is the general way the skin, mucous membranes, immune system cells and proteins fights germs. The experiment was done in blood samples in the lab, but the immune system may react differently in real life. Those mice cleared a bacterial infection less efficiently and with a less-robust immune response than mice that weren’t exposed.

Persons: they’ve, it’s, ”, Dr, Violaine, “, André, Darragh Duffy, “ It’s, ” Duffy, Duffy, Yasmin Thanavala, There’s, ” Thanavala, Sanjay Gupta, Albert Rizzo, we’ve, Rizzo Organizations: CNN, Nature, Institut Pasteur, Immunology, Roswell, Cancer Institute, Get CNN, CNN Health, American Medical Association Locations: United States, Paris

☆ Eli Lilly's Zepbound is off to a strong start, but here's what needs to happen to push shares higher
▼ + stars: | 2024-01-24 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +8 min

Lilly's Mounjaro and Zepbound both use tirzepatide as an active ingredient, but Mounjaro is indicated for type 2 diabetes, while Zepbound aids weight loss. A rich valuation LLY 1Y mountain Eli Lilly shares over the past year. But even good news about Zepbound's launch might not be enough to propel Lilly's stock higher. Goldman's Shibutani has a neutral rating on Lilly shares and a price targe of $600, which implies shares could fall nearly 5% from they started the week. He has a buy rating on Lilly shares, and expects the stock could hit $700 over the next 12 months.

Persons: Eli Lilly's, Lilly, Goldman Sachs, Chris Shibutani, IQVIA, Shibutani, Lilly's, Mounjaro, Eli Lilly, Geoff Meacham, NASH, Meacham, there's, Morgan Stanley, Terence Flynn, Flynn, Morgan Stanley's, Michael Bloom Organizations: Food and Drug Administration, Zepbound, Novo Nordisk's, Medicare, Bank of America, Novo Nordisk, Bank of, FDA, CNBC Locations: Indianapolis, Mounjaro

☆ Antibiotic-resistant germs are killing us. Microscopic viruses may be the answer
▼ + stars: | 2024-01-21 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +14 min

Last year doctors offered to treat Horton’s infection with one of nature’s oldest predators — tiny tripod-looking viruses called phages designed to find, attack and gobble up bacteria. SCIEPRO/Science Photo Library/Getty ImagesThe microscopic creatures have saved the lives of patients dying from superbug infections and are being used in clinical trials as a potential solution to the growing problem of antibiotic resistance. Would the bacteria from her ear help scientists find phages that would treat the eye infections as well? By the following January, the CDC said at least 50 patients in 11 states had developed superbug infections after using preservative‐free artificial tears. It was a qualified success: The antibiotic-resistant bacteria in five patients were eradicated, while several more patients showed improvements.

Persons: Cynthia Horton’s earaches, “, ”, Dwayne Roach, Eager, Horton, Maroya Walters, ” Walters, Tom Patterson, Steffanie, Paul Turner, “ Iraqibacter, Patterson, Strathdee, Tom, ” Strathdee, Tom Patterson's, Rather, Anthony Maresso, ” Maresso, “ It’s, ” Roach, phages, Elizabeth Villa, Jumbo phages, Robert “ Chip ”, ” Schooley, Juliette Robert, Haytham, REA, CDC’s Walters Organizations: CNN, San Diego State University ., US Centers for Disease Control, Center, Therapeutics, UC San Diego School of Medicine, UC, Diego’s, CDC, Yale University, Yale School of Medicine, UC San, UC San Diego, ”, San Diego, Baylor College of Medicine, Eliava Institute Locations: United States, North America, Pennsylvania, IPATH, Iraq, New Haven , Connecticut, UC San Diego, Turner’s Yale, San, San Diego State, Texas, Houston, Russia, Georgia, Tbilisi , Georgia

☆ Sanofi CEO Paul Hudson: We've got perhaps the world's best immunology pipeline
▼ + stars: | 2024-01-18 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSanofi CEO Paul Hudson: We've got perhaps the world's best immunology pipelineSanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's plan to become an immunology powerhouse, drug pipeline outlook, using AI for future drug discoveries, and more.

Persons: Paul Hudson, We've Organizations: Sanofi

☆ Why we like health-care stocks in 2024 despite their spotty record in presidential election years
▼ + stars: | 2024-01-18 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +11 min

The S & P 500 Health Care Sector index has outperformed the broader S & P 500 in just three of the past eight presidential election years dating back to 1992, according to FactSet data. So far in 2024, health care has been the best-performing sector in the S & P 500, climbing roughly 2%. .GSPHC .SPX YTD mountain Health care sector vs. S & P 500 YTD It's way too early for any grand predictions with Election Day 2024 about 10 months away. Nevertheless, we see attractive fundamentals in the year ahead for a host of health-care stocks, giving us the confidence to own Lilly, GE Healthcare and Danaher despite what history says about the group in presidential election years. After a strong 2022 for health care in a terrible overall market, investors last year placed a lower emphasis on the defensive characteristics of health care.

Persons: —, that's, Eli Lilly, Lilly, Jim Cramer, Jim, Sen, Bernie Sanders of, Joe Biden, Sanders, would've, Damien Conover, Conover, Biden, Eli Lilly's, Morningstar, Amgen, Morningstar's Conover, Lilly's donanemab, Humana, Bausch, Jim Cramer's, Frederick Florin Organizations: Health, GE Healthcare, Abbott Laboratories, Amgen, Novartis, Walgreens Boots Alliance, JPMorgan Healthcare Conference, Democratic, Morningstar, CNBC, Horizon Therapeutics, Novo Nordisk, Federal Reserve, General Electric, Medicare, Humana, UnitedHealth Group, Investors, AFP, Getty Locations: San Francisco, U.S, Bernie Sanders of Vermont, Canadian, Fegersheim, France

☆ Stability AI: Cofounder Sues Startup Behind Stable Diffusion for up to $300 Million
▼ + stars: | 2024-01-17 | by ( Riddhi Kanetkar | ) www.businessinsider.com time to read: +3 min

Tayab Waseem claims that he was a cofounder in Stability AI and that the company has reneged on its promise of a 10% stake in the London-based AI startup. Stability AI rose to prominence in 2022 when users flooded its Stable Diffusion program, generating images of everything from hyperrealistic portraits to fantasy landscapes. Stability AI raised an undisclosed amount from Intel in October 2023. Waseem joined Stability AI when the cofounders, Mostaque and Hodes, were launching a project called CAIAC, which used AI to combat COVID-19, Waseem told BI. AdvertisementAccording to the filing, Stability AI had not paid him a formal salary due to cash flow problems, instead promising him 10% in equity interest.

Persons: —, Tayab Waseem, Emad Mostaque, Cyrus Hodes, Mostaque, Mike Bloomberg, Waseem Organizations: Service, Business, Intel, Getty Images, Bloomberg, Court, Eastern, of Locations: London

☆ Ancient DNA reveals genetic roots of multiple sclerosis and other diseases
▼ + stars: | 2024-01-11 | by ( Katie Hunt | ) edition.cnn.com time to read: +8 min

These genetic variants may have subsequently proved beneficial to European populations in making the shift from hunting and gathering to farming. “DNA from hunter-gatherers is present at higher levels in Northeastern Europe, which means the region has an elevated genetic risk of developing Alzheimer’s disease,” Barrie said. Similarly, the ancient genetic information shed light on the evolutionary history of traits such as height and lactose tolerance. And for most traits, MS included, the genetic effects are the result of multiple genetic variants,” he said. “Ultimately, we can’t say that MS came from Bronze Age populations, but these populations’ movements and environments contribute to differences in MS risk today.”

Persons: “, ”, Rasmus Nielsen, It’s, William Barrie, Astrid Iversen, ” Iversen, ε4, ” Barrie, Samira, Asgari, Tony Capra, Capra, wasn’t Organizations: CNN —, University of California, Danish National, University of Cambridge’s, University of Oxford, Icahn School of Medicine, Bakar Computational Health Sciences Institute Locations: Western Europe, Central Asia, Europe, Berkeley, Kazakhstan, Northeastern Europe, Mount Sinai, New York, Bakar, San Francisco

☆ Jimmy Kimmel Isn’t Expecting an Apology From Aaron Rodgers
▼ + stars: | 2024-01-09 | by ( Trish Bendix | ) www.nytimes.com time to read: +2 min

Kimmel cited Rodgers’ “Thanksgiving Day Parade-sized ego” as part of the problem and said he wasn’t expecting an apology, but he did want to differentiate between the jokes made on “Jimmy Kimmel Live” and flat-out lies. I apologize for it, which is what Aaron Rodgers should do, which is what a decent person would do. I’ll accept his apology and move on.” — JIMMY KIMMEL“But here’s the thing: I spent years doing sports. Aaron Rodgers has a very high opinion of himself. The idea that his brain is just average is unfathomable to him.” — JIMMY KIMMEL“We learned during Covid somehow he knows more about science than scientists.

Persons: Kimmel, Rodgers ’, wasn’t, Jimmy Kimmel, Donald Trump, Aaron Rodgers, ” — JIMMY KIMMEL, I’ve, God, ” — JIMMY KIMMEL “, Covid, — JIMMY KIMMEL “ Aaron, Aaron, ’, JIMMY KIMMEL “ Organizations: Cal

☆ Oprah's flip on weight loss drugs is a sign of what's to come for the 'Ozempic trade' in 2024
▼ + stars: | 2023-12-25 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +10 min

Lilly's Zepbound recently entered the weight loss market, and is off to a strong start. But what's ahead for the weight loss trade in 2024? Beyond weight loss One of 2023's most pivotal events in the space was Novo Nordisk's release of top line results from its Select trial in August . In 2023, the exuberance around weight loss drugs roiled markets in many unexpected ways. The affected companies have also been very vocal in addressing how they plan to coexist with these weight loss products.

Persons: Oprah Winfrey, Eli Lilly, they've, Lilly's, Lilly's Zepbound, Andy Acker, Janus Henderson's, Lilly, Novo, FactSet, Acker, Janus, Buzz, Gregory Renza, Renza, Goldman Sachs, Chris Shibutani, Mike Kratky, Kratky, Dexcom, Leerink, Winfrey, I've, Winfrey's, Michael Bloom Organizations: Novo Nordisk, Wall Street, Wall, RBC Capital, Pfizer, Structure Therapeutics, AstraZeneca, Leerink, Nestle, Oprah Daily, Winfrey, International Locations: Friday's, Eccogene, MedTech, 3Q23

Search resuls for: "Immunology"

25 mentions found